All News #Library
Biotech
Cognition Therapeutics To Present At Needham Healthcare Conf
07 Apr 2026 //
GLOBENEWSWIRE
Cognition Therapeutics CEO Issues Letter To Shareholders
31 Mar 2026 //
GLOBENEWSWIRE
Cognition Therapeutics Reports 2025 Results, Clinical Updates
26 Mar 2026 //
GLOBENEWSWIRE
Cognition Therapeutics Shows Zervimesine`s Effect On Dementia
17 Mar 2026 //
GLOBENEWSWIRE
Cognition Advances Zervimesine for Lewy Body Dementia Psychosis
02 Mar 2026 //
GLOBENEWSWIRE
Cognition Therapeutics Wraps FDA Type C Meeting For Zervimesine
27 Jan 2026 //
GLOBENEWSWIRE
Cognition Therapeutics Unveils Zervimesine Phase 3 Plan in AD
01 Dec 2025 //
GLOBENEWSWIRE
Cognition Secures $30M for Phase 3 Zervimesine Development
02 Sep 2025 //
GLOBENEWSWIRE
Cognition Therapeutics Reports Q2 2025 Financial Results
07 Aug 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support